These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8657645)

  • 1. [The importance of interleukin 6 (IL-6) in pathogenesis and diagnosis of renal glomerular diseases].
    Kacprzyk F
    Postepy Hig Med Dosw; 1995; 49(4):513-22. PubMed ID: 8657645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.
    Horii Y; Iwano M; Hirata E; Shiiki M; Fujii Y; Dohi K; Ishikawa H
    Kidney Int Suppl; 1993 Jan; 39():S71-5. PubMed ID: 8468929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of IL-6 in mesangial proliferative glomerulonephritis.
    Horii Y; Muraguchi A; Iwano M; Matsuda T; Hirayama T; Yamada H; Fujii Y; Dohi K; Ishikawa H; Ohmoto Y
    J Immunol; 1989 Dec; 143(12):3949-55. PubMed ID: 2592764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid measurement of urinary IL-6 by ELISA: urinary IL-6 as a marker of mesangial proliferation.
    Hirata E; Iwano M; Hirayama T; Horii Y; Kitamura Y; Kishimoto T; Hanatani M; Dohi K
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):33-7. PubMed ID: 8107306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract.
    Ohta K; Takano N; Seno A; Yachie A; Miyawaki T; Yokoyama H; Tomosugi N; Kato E; Taniguchi N
    Clin Nephrol; 1992 Oct; 38(4):185-9. PubMed ID: 1424304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum and urinary interleukin-6 levels in patients with primary glomerulonephritis].
    Hrvacević R; Topalov D; Stojanović R; Lilić D; Dimitrijević J; Maksić Dj; Marić M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():40-2. PubMed ID: 9102925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.
    Chadban SJ; Tesch GH; Foti R; Atkins RC; Nikolic-Paterson DJ
    Lab Invest; 1997 May; 76(5):619-27. PubMed ID: 9166281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid and mesangial cells: implications for renal diseases.
    Inoue CN; Epstein M; Forster HG; Hotta O; Kondo Y; Iinuma K
    Clin Sci (Lond); 1999 Apr; 96(4):431-6. PubMed ID: 10087253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary IL-6: a marker for mesangial proliferative glomerulonephritis?
    Gordon C; Richards N; Howie AJ; Richardson K; Michael J; Adu D; Emery P
    Clin Exp Immunol; 1991 Oct; 86(1):145-9. PubMed ID: 1914227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of low-molecular weight heparin on urine interleukin-6 in patients with proliferative glomerulonephritis].
    Zhang H; Ji LZ; Dai ZW
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):443-4. PubMed ID: 12536495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of mesangial injury in glomerular diseases.
    Daha MR
    J Nephrol; 2000; 13 Suppl 3():S89-95. PubMed ID: 11132039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular enlargement in the progression of mesangial proliferative glomerulonephritis.
    Daimon S; Koni I
    Clin Nephrol; 1998 Mar; 49(3):145-52. PubMed ID: 9543595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG-associated mesangial glomerulonephritis in a patient with Down syndrome.
    Assadi FK
    Med Sci Monit; 2004 Sep; 10(9):CS54-6. PubMed ID: 15328491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrectomy enhances interleukin 6 secretion by interleukin 1-stimulated mesangial cells in vitro.
    Weissgarten J; Golik A; Cohn M; Dishi V; Cohen N; Berman S; Modai D; Averbukh Z
    J Nephrol; 1998; 11(4):199-202. PubMed ID: 9702871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
    Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
    Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal synthesis of leukaemia inhibitory factor (LIF), under normal and inflammatory conditions.
    Morel DS; Taupin JL; Potier M; Deminière C; Potaux L; Gualde N; Moreau JF
    Cytokine; 2000 Mar; 12(3):265-71. PubMed ID: 10704254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage].
    Egido J; Gómez-Chiarri M; Lerma JL; González E; Maestre C; Ortiz A; Hernando L
    Rev Clin Esp; 1990; 187(3):137-43. PubMed ID: 2284487
    [No Abstract]   [Full Text] [Related]  

  • 19. Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin.
    Kayama F; Yoshida T; Kodama Y; Matsui T; Matheson JM; Luster MI
    Cytokine; 1997 Sep; 9(9):688-95. PubMed ID: 9325018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
    De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
    J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.